Indevus Announces Initiation of Phase III Trial of PRO 2000

Indevus Announces Initiation of Phase III Trial of PRO 2000
Genetic Engineering News, NY - Oct 25, 2005 PRO 2000, the Company's topical, vaginal microbicide in development for the prevention of sexually transmitted infections, including HIV, herpes, chlamydia and

Cellegy Announces Update to Savvy Phase 3 HIV Prevention Trials
PR Newswire (press release), NY - 9 hours ago 100% enrollment has been achieved in the Savvy(R) (C31G vaginal gel) Phase sexually transmitted diseases (STDs), including those caused by herpes simplex virus

HEALTH CALENDAR
Kansas.com, KS - Oct 23, 2005 fibromyalgia, rheumatoid arthritis, dry eye, irritable bowel syndrome, diabetes with depression, herpes vaccine, obesity, vaginal infection, prevention of bone

Cervical cancer
drkoop.com - Oct 25, 2005 are at risk of a rare form of cervical and vaginal cancer. Infections with genital herpes or chronic chlamydia infections, both sexually transmitted diseases

Herpes